Listing of Theranexus on Euronext Growth - Franck Mouthon and Mathieu Charvériat, founders of Theranexus 00:00:00
Theranexus is an innovative biopharmaceutical company specializing in the development of therapeutic products for the treatment of central nervous system diseases. Theranexus now has one product (THN102; a drug candidate combining a modulator of neuronal activity with a glial connexin modulator for the treatment of narcolepsy, a rare neurological disease) in Phase II clinical trial.
